000027974 000__ 05359cam\a2200577\i\4500
000027974 001__ 27974
000027974 003__ SzGeWIPO
000027974 005__ 20230203214423.0
000027974 008__ 161116s2017\\\\enka\\\\rb\\\\001\0\eng\d
000027974 015__ $$aGBB786502$$2bnb
000027974 0167_ $$a018350882$$2Uk
000027974 020__ $$a9781783479443$$qPrint
000027974 020__ $$z9781783479450$$qeBook
000027974 035__ $$a(wipo)010920537
000027974 035__ $$a(OCoLC)964380883
000027974 040__ $$aStDuBDS$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000027974 041__ $$aeng
000027974 043__ $$ae-sz---
000027974 050_4 $$aK1519.B54$$bR47 2017
000027974 08204 $$a346.048$$223
000027974 08204 $$a346.0482$$220
000027974 084__ $$aG 25 MAT.R$$223
000027974 1001_ $$aMatthews, Duncan.,$$aZech, Herbert.$$eEditors.
000027974 24500 $$aResearch Handbook on Intellectual Property and the Life Sciences
000027974 264_1 $$aCheltenham, UK :$$bEdward Elgar Publishing,$$c2017.
000027974 300__ $$a528 pages :$$billustrations ;$$c25 cm.
000027974 336__ $$atext$$btxt$$2rdacontent
000027974 337__ $$aunmediated$$bn$$2rdamedia
000027974 338__ $$avolume$$bnc$$2rdacarrier
000027974 4901_ $$aResearch handbooks in intellectual property
000027974 504__ $$aIncludes bibliographical references and index.
000027974 5050_ $$aPreface -- Part I - Medicine and Pharmaceutics - 1. Patenting Biosimilars. 2. Patenting Diagnostics. 3. Patenting Human Genes in Europe- And how it compares to the US and Australia. 4. Patenting Human Genes in the United States. 5. An Exorbitant Monopoly: The High Court of Australia, Myriad Genetics, and Gene Patents. 6. Exclusivity for Biologics -- Part II - Agricultural Sector (Crop Sciences) - 7. Protection of Plant Innovations. 8. Patenting Non Transgenic Plants in the EU. 9. Non-Obvious Plants. 10. Transgenic Plants. 11. Convention on Biological Diversity and Regulatory Law as Plant Protection. 12. Patents on Native Traits: What Scope of Protection? -- Part III - Research and Development. 13. The European Union’s IP Policy and Funding of Stem Cell Research. 14. Stem Cell Patents in the United States. 15. Early Stage Patenting, the US Bayh-Dole Act, and the Anti-Commons Hypothesis. 16. IP in Research and Development Agreements. 17. Patent pools and clearinghouses in the life sciences: back to the future -- Part IV - Country Case Studies in IP and the Life Sciences - 18. Understanding the Brazilian Patent Reform. 19. IP protection in the life sciences in China. 20. Diverse Harmonization: Indian Example. 21. Life Science Research and Patents in Japan: A Comparative Study of Life Science Invention Patentability between the Japanese and US Patent Acts. 22. Intellectual Property and the Life Sciences in Kenya: Enforcement and Access to Medicines. 23. IP and Life Sciences: A Case Study of South Africa. 24. Thailand’s Compulsory Licenses and the Increase of Investment Arbitration -- Part V - Boundaries of IP and the Life Sciences - 25. Parallel Imports within the European Union - 26. Pay for Delay Agreements. 27. Abusive Filing of IP Rights -- Index
000027974 520__ $$aIntellectual property (IP) is a key component of the life sciences, which is becoming one of the most dynamic and innovative fields of technology today. At the same time, the relationship between IP and the life sciences is raising new public policy dilemmas. The Research Handbook on Intellectual Property and the Life Sciences comprises contributions by leading experts from academia and industry that confront current debates and controversies at the intersection of IP and the life sciences through in-depth analyses of key topics including pharmaceuticals, diagnostics and genes, plant innovations, stem cells, the role of competition law and access to medicines.  The first section of this book highlights the importance of IP for medicines and pharmaceuticals, discussing topics including gene patents, and the second section deals with agricultural sector issues such as plant innovations. The third section of the book covers areas of research and development in the life sciences, such as stem cell research, and raises questions about incorporating ethical considerations into patent law. While the primary focus of the book is on Europe and the United States, the fourth section includes country-specific case studies on Australia, Brazil, China, India, Japan, Kenya, South Africa and Thailand to provide a truly international perspective.  This Research Handbook is written in an accessible style that will appeal to intellectual property law scholars, practitioners and experts in the life sciences who are interested in the legal implications of IP for the life sciences.
000027974 650_0 $$aLife sciences$$xLaw and legislation.
000027974 650_0 $$aLife sciences$$zSwitzerland.
000027974 650_0 $$aIntellectual property.
000027974 650_0 $$aBiotechnology industries$$xLaw and legislation.
000027974 650_0 $$aLife sciences.
000027974 650_0 $$aIntellectual property$$zSwitzerland.
000027974 650_0 $$aPatents$$zSwitzerland.
000027974 651_0 $$aSwitzerland$$xCommerce$$xLaw and legislation.
000027974 655_7 $$aKonferenzschrift$$zBasel$$y2015$$2gnd-content
000027974 7001_ $$aJ. Allred,$$aT. Avafia,$$aC. Chiarolla,$$aD.B. Degen,$$aJ.M. Golden,$$aM. Graf,$$aJ. Harrington,$$aA. Heinemann,$$aM.D. Janis,$$aM.A. Kock,$$aX. Lin,$$aC.R. McManis,$$aA. Metzger,$$aT. Minssen,$$aC. Mund,$$aP. Paranaguá,$$aA. Plomer,$$aS. Ragavan,$$aM. Rimmer,$$aC. Seitz,$$aT. Takenaka,$$aG. Van Overwalle,$$aD. Wächter,$$aG. Würtenberger,$$aZ. Xinfeng,$$aB. Yagi,$$aB. Yao$$eContributors.
000027974 852__ $$bZ01$$c02$$h2017 B 13076$$pZM03526437
000027974 85641 $$uhttps://www.elgaronline.com/display/edcoll/9781783479443/9781783479443.xml$$yView eBook
000027974 903__ $$aResearch Handbooks in Intellectual Property series
000027974 942__ $$2ddc$$cMON
000027974 952__ $$w2017-12-11$$p2017-0040$$u42317$$bMAIN$$10$$kG 25 MAT.R$$v2017-12-11$$zTagged$$70$$yMON
000027974 980__ $$aBIB$$aOS
000027974 999__ $$c30671$$d30671